The average woman age at thefirst conception is increasing worldwide. The incidence of meiotic errors and chromosomal impairments in gametes and embryos increases with maternal aging. The consequent reduction in fecundity and fertility is then associated with a higher demand for Assisted Reproductive Technology (ART) to counteract such issue. In advanced maternal age (AMA) women, several reproductive insults are due to aging, encompassing reduced ovarian reserve, impaired oogenesis, altered follicular metabolism, compromised embryo competence, defective physiological pathways, epigenetic deregulation and lack of cell cycle checkpoints. In this review, we provide an overview of the most recent evidences and theories focused on maternal aging, outlining what is known about the putative biochemical and molecular mechanism underlying its inherent dysfunctions. We also briefly discuss the already established and the most promising future strategies designed to improve the management of AMA patients in IVF.

Conséquences biologiques de l’âge maternel avancé sur la reproduction. Biological consequences of advanced maternal age in reproduction

Danilo Cimadomo;
2019-01-01

Abstract

The average woman age at thefirst conception is increasing worldwide. The incidence of meiotic errors and chromosomal impairments in gametes and embryos increases with maternal aging. The consequent reduction in fecundity and fertility is then associated with a higher demand for Assisted Reproductive Technology (ART) to counteract such issue. In advanced maternal age (AMA) women, several reproductive insults are due to aging, encompassing reduced ovarian reserve, impaired oogenesis, altered follicular metabolism, compromised embryo competence, defective physiological pathways, epigenetic deregulation and lack of cell cycle checkpoints. In this review, we provide an overview of the most recent evidences and theories focused on maternal aging, outlining what is known about the putative biochemical and molecular mechanism underlying its inherent dysfunctions. We also briefly discuss the already established and the most promising future strategies designed to improve the management of AMA patients in IVF.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1531424
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact